BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Amniocentesis
,
Rosiglitazone
,
rs2476601
,
CYP51
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
HCC 1
Summary
General Info
Curated Studies
Most Correlated Studies
Hepatocellular carcinoma (HCC) - gene expression signatures of NANOG+ and NANOG- HCC cells
Livers of sorafenib-treated hepatocellular carcinoma (HCC) model
HCC Hep G2 cells with nimesulide, nefazodone, trovafloxacin, aspirin, buspirone or levofloxacin
Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) expression profiles
Hepatocellular carcinoma (HCC) and adjacent tissue expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
Structural basis for high-order complex of SARNP and DDX39B to facilitate mRNP assembly.
Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carc…
External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent ac…
CCL14 exacerbates intraplaque vulnerability by promoting neovascularization in the human carotid pla…
Performance of urinary C-C motif chemokine ligand 14 for the prediction of persistent acute kidney i…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Postoperative Adjuvant Therapy of HCC Based on PD-1
RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)
Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient
Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refracto…
Ablation Combined With PD-1 in HCC: Phase II Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ